Aurora Cannabis Files 6-K for Q3 2024 Period

TL;DR

Aurora Cannabis filed its Q3 2024 6-K, incorporating it into their F-10 registration. Check for updates.

AI Summary

Aurora Cannabis Inc. filed a Form 6-K on February 5, 2025, for the period ending December 31, 2024. The company is a foreign private issuer and is submitting its report under the 1934 Act. This filing is incorporated by reference into their Registration Statement on Form F-10.

Why It Matters

This filing provides updated information for investors regarding Aurora Cannabis's financial reporting period, which is crucial for understanding the company's ongoing performance and financial health.

Risk Assessment

Risk Level: low — This is a routine periodic filing (6-K) that primarily serves to update information and does not appear to contain significant new disclosures or events.

Key Players & Entities

• AURORA CANNABIS INC (company) — Filer
• 0001683541-25-000004 (accession_number) — Filing identifier
• 20241231 (date) — Reporting period end date
• 20250205 (date) — Filing date
• 2833 (sic_code) — Standard Industrial Classification
• 001-38691 (sec_file_number) — SEC file number
• 333-271479 (registration_statement_file_number) — Incorporated registration statement file number

FAQ

From the Filing

0001683541-25-000004.txt : 20250205 0001683541-25-000004.hdr.sgml : 20250205 20250205071512 ACCESSION NUMBER: 0001683541-25-000004 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250205 DATE AS OF CHANGE: 20250205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 25590886 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 form6-k20241231q32025.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F   [ ] Form 40-F  [X] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  [ ] This Form 6-K is hereby filed and incorporated by reference in the registrant’s Registration Statement on Form F-10 (File No. 333-271479). SUBMITTED HEREWITH Exhibits Description 99.1 Condensed Consolidated Interim Financial Statements for the three and nine months ended December 31, 2024 and 2023 99.2 Interim Management’s Discussion and Analysis for the three and nine months ended December 31, 2024 and 2023 99.3 Certification of Chief Executive Officer 99.4 Certification of Chief Financial Officer      SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Simona King              Simona King Chief Financial Officer Date: February 5, 2025      EX-99.1 2 fs20241231q32025.htm EX-99.1 Document AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) 4 Condensed Consolidated Interim Statements of Changes in Equity 6 Condensed Consolidated Interim Statements of Cash Flows 8 Notes to the Condensed Consolidated Interim Financial Statements Note 1 Nature of Operations 9 Note 11 Share-Based Compensation 20 Note 2 Material Accounting Policies and Judgments 9 Note 12 Income (Loss) Per Share 23 Note 3 Biological Assets 13 Note 13 Other Gains (Losses) 24 Note 4 Inventory 14 Note 14 Supplemental Cash Flow Information 25 Note 5 Property, Plant and Equipment 15 Note 15 Commitments and Contingencies 25 Note 6 Assets Held for Sale and Discontinued Operations 16 Note 16 Revenue 27 Note 7 Intangible Assets and Goodwill 17 Note 17 Segmented Information 28 Note 8 Loans and Borrowings 18 Note 18 Fair Value of Financial Instruments 30 Note 9 Lease Liabilities 19 Note 19 Financial Instruments Risk 30 Note 10 Share C